sends news that researchers from Mayo Clinic have successfully put a patient's cancer into remission using a modified measles virus
. The researchers are quick to note that further trials are needed to determine whether these results are repeatable. Here are the two academic papers
"Multiple myeloma in a 49-year-old woman seemed to disappear after she received an extremely high-dose injection of a measles virus engineered to kill the cancer cells. Multiple myeloma affects immune cells called plasma cells, which concentrate in the soft tissue, or marrow, inside bones. A second woman also with multiple myeloma began responding to the therapy, but her cancer eventually returned. Four other patients who received the high-dose therapy had no response. .. [Dr. Stephen Russell] and colleagues believe the two women who showed some response had few or no circulating measles antibodies, which might eliminate the engineered virus before it has a chance to kill the cancer cells. The therapy will now enter a mid-stage trial to see whether more patients with low circulating antibodies respond to high-doses of the virus, he said."